Participating Companies at BioPharm America™ 2010
BioPharm America™ attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.
0-9AB CDE FGH IJ K LMN OPQ RST UVW XYZ
| Number of companies: 565 | |
| 0-9 | Top of Page |
| 4-Antibody | Switzerland |
| 7TM Pharma | Denmark |
| A | Top of Page |
| A. Menarini IFR | Italy |
| Aagami, Inc | United States |
| Abbott Biotech Ventures | United States |
| Abbott Laboratories, Inc. | United States |
| AbGenomics Int'l | United States |
| Ablynx nv | Belgium |
| Acceleron Pharma | United States |
| Aceras BioMedical LLC | United States |
| Acetylon Pharmaceuticals Inc. | United States |
| Actelion Pharma Limited | Switzerland |
| Actelion Pharmaceuticals Canada | Canada |
| Actelion Pharmaceuticals do Brasil Ltda | Brazil |
| Addex Pharmaceuticals | Switzerland |
| Adenios Inc. | United States |
| AdeTherapeutics Inc. | Canada |
| Adimab Inc. | United States |
| Adjuvant Partners | United States |
| AEC PARTNERS | France |
| AEterna Zentaris GmbH | Germany |
| AiCuris GmbH & Co. KG | Germany |
| Ajinomoto Pharmaceuticals Co., Ltd | Japan |
| Akebia Therapeutics | United States |
| ALAXIA | France |
| Alexion Pharmaceuticals | United States |
| Alfama Inc. | United States |
| Algol Pharma | Finland |
| ALIZE PHARMA | France |
| Alkermes, Inc. | United States |
| Alligator Bioscience AB | Sweden |
| Allostera Pharma, Inc. | Canada |
| Alnylam Pharmaceuticals | United States |
| Alpharmaxim | United Kingdom |
| Alsace BioValley | France |
| Alsace BioValley | United States |
| Altiris Therapeutics, Inc. | United States |
| Altran | United States |
| Amakem NV | Belgium |
| Amarantus Therapeutics, Inc. | United States |
| Amgen, Inc | United States |
| AMRI | United States |
| AMT B.V. | Netherlands |
| AMYLGEN | France |
| Anchor Therapeutics | United States |
| Angel Biotechnology PLC | United Kingdom |
| Angelini | Italy |
| Anoto | Sweden |
| Antisense Therapeutics Ltd | Australia |
| Antisoma Inc. | United States |
| Aperion BioPharma Advisors | United States |
| Applied Pharma Research USA | United States |
| Apposite Capital | United Kingdom |
| Aptis Partners | United States |
| Aquapharm Biodiscovery Ltd | United Kingdom |
| Aquinox Pharmaceuticals | Canada |
| arGEN-X BV | Netherlands |
| Ascalon International | United States |
| ASK Diagnostics, Inc. | United States |
| Assign Clinical Research GmbH | Austria |
| Astellas Pharma Inc | Japan |
| AstraZeneca | United States |
| ATGCell Inc. | Canada |
| aTyr Pharma | United States |
| Aurigene Discovery Technologies Ltd | India |
| Axeuron Therapeutics, LLC | United States |
| Axios Biosciences | United States |
| B | Top of Page |
| Bach Pharma, Inc. | United States |
| Baker McKenzie | United Kingdom |
| BayBio | United States |
| Bayer Healthcare Pharmaceuticals | Germany |
| Beech Tree Labs | United States |
| Beth Israel Deaconess | United States |
| BGI (formerly known as Beijing Genomics Institute) | China |
| BHR Group Ltd | United Kingdom |
| Bingham McCutchen LLP | United States |
| Bio-Link Australia | Australia |
| BIO-MODELING-SYSTEMS | France |
| BioAdvance | United States |
| BioBehavioral Diagnostics | United States |
| BioCentury Publications | United States |
| Biocrates Life Sciences AG | Austria |
| Biogen Idec | United States |
| BIOGroup RI | United States |
| BioInvent International AB | Sweden |
| BiolineRx | Israel |
| BioMentorz, Inc. | United States |
| BioRN Cluster Management GmbH | Germany |
| BioServe | United States |
| bioskin GmbH | Germany |
| BIOTECanada | Canada |
| BioTechLogic, Inc. | United States |
| Biotechnology Industry Organization | United States |
| Biotecnol Pharmaceuticals, Inc | United States |
| Biotis | Israel |
| Biovista, Inc. | United States |
| bioVolutions Inc. | United States |
| BioWa, Inc. | United States |
| BioWorld/AHC Media | United States |
| BioXcel Corporation | United States |
| Boehringer Ingelheim Pharma | Germany |
| Bristol-Myers Squibb | United States |
| Burrill & Company | United States |
| Business Wire | United States |
| C | Top of Page |
| C14 Consulting Group, LLC | United States |
| Campbell Alliance | United States |
| Camurus AB | Sweden |
| Capstone Therapeutics | United States |
| Carolus Therapeutics, Inc. | United States |
| Catalonia Trade & Invest-ACC10 | United States |
| celares GmbH | Germany |
| Celator Pharmaceuticals | United States |
| Celgene Corporation | United States |
| CellSeed | Japan |
| Cenduit | United States |
| CenterWatch | United States |
| Cephalon | United States |
| CEPTON Strategies | Germany |
| Cerulean Pharma Inc. | United States |
| Cevec Pharmaceuticals GmbH | Germany |
| Charles River Laboratories | United States |
| Children's Hospital Boston/Harvard Medical School | United States |
| ChinaBio, LLC | China |
| Chiome Bioscience Inc. | Japan |
| Choate, Hall & Stewart | United States |
| Choongwae Holdings Co. | South Korea |
| CJ CheilJedang Corp. | South Korea |
| Clean Membranes Inc | United States |
| Clinical Development and Support Services Ltd (CDSS) | United Kingdom |
| Coats + Bennett, PLLC | United States |
| Combinent BioMedical Systems | United States |
| CoNCERT Pharmaceuticals | United States |
| Conformetrix | United Kingdom |
| Congenix LLP | Russian Federation |
| Constellation Pharmaceuticals | United States |
| Consulate General of Canada | United States |
| Copenhagen Capacity | Denmark |
| Corium International | United States |
| Creative Places | United Kingdom |
| CRELUX GmbH | Germany |
| Critical Outcome Technologies Inc. | Canada |
| Crucell | United States |
| CSOFT International, Ltd. | China |
| CTPartners | United States |
| Cubist Pharmaceuticals | United States |
| CUREMARK | United States |
| CXR Discovery | United Kingdom |
| D | Top of Page |
| Daewoong Pharmaceuticals Co. Ltd. | South Korea |
| Dainippon Sumitomo Pharma Co., Ltd. | Japan |
| Dallas Computer Services | United States |
| Dalton Pharma Services | Canada |
| Defined Health | United States |
| Deloitte | United States |
| Demy-Colton Life Science Advisors | United States |
| Depomed, Inc. | United States |
| Dicerna Pharmaceuticals | United States |
| Dong-A Pharmaceuticals | South Korea |
| Druid BioVentures | United States |
| DSM Biomedical | Netherlands |
| Dyax Corp | United States |
| E | Top of Page |
| EBD Group | Switzerland |
| Eczacibasi Ilac Pazarlama | Turkey |
| Eds Integrated Services Ltd | United States |
| Edwards Angell Palmer & Dodge | United States |
| EGeen International | United States |
| Elan Drug Technologies | United States |
| Elara Pharmaceuticals GmbH | Germany |
| Elcam Medical | Israel |
| Elevation Pharmaceuticals | United States |
| Eli Lilly and Company | United States |
| Elsevier Business Intelligence | United States |
| Embassy of Denmark | United States |
| Embera NeuroTherapeutics, Inc. | United States |
| Endo Pharmaceuticals | United States |
| Ensemble Therapeutics | United States |
| ENTRA Pharmaceuticals | United States |
| EnVivo Pharmaceuticals | United States |
| EOStrat | Canada |
| Epitomics, Inc. | United States |
| ERA Consulting | United States |
| Ernst & Young LLP | United States |
| ERYTECH PHARMA | France |
| ESC Advisors | United States |
| Esperion Therapeutics | United States |
| Essentialis, Inc. | United States |
| Eurand | United States |
| Europa Rx Ltd | United Kingdom |
| EvaluatePharma | United States |
| Excelimmune, Inc. | United States |
| Exelixis | United States |
| F | Top of Page |
| FAB Pharma | France |
| FasterCures | United States |
| Fate Therapeutics, Inc. | United States |
| Fenway Pharmaceuticals | United States |
| FGK Clinical Research GmbH | Germany |
| FierceBiotech | United States |
| Fish & Richardson, P.C. | United States |
| Flamel Technologies, Inc | United States |
| Flex Biomedical, Inc. | United States |
| FORENAP PHARMA | France |
| Formerly with Coley Pharmaceuticals | United States |
| Fox Chase Cancer Center | United States |
| FreeMind Group | United States |
| Future Diagnostics | United States |
| G | Top of Page |
| GBS Ventures | Australia |
| GE Trading and Licensing | United States |
| Genentech, Inc. | United States |
| Genetic Microdevices | United Kingdom |
| Genfit | France |
| GenomeQuest | United States |
| Genovis Ab | Sweden |
| GenScript | United States |
| Genta Incorporated | United States |
| Genzyme Corporation | United States |
| Germany Trade & Invest GmbH | Germany |
| GlaxoSmithKline | United Kingdom |
| Goodwin Procter | United States |
| greenovation Biotech GmbH | Germany |
| Gunderson Dettmer Stough, Villeneuve Franklin & Hachigian, LLP | United States |
| GVK Biosciences Private Limited | India |
| H | Top of Page |
| Halloran Consulting Group | United States |
| Han Wha Pharma Co., Ltd. | South Korea |
| Hanall Pharmaceutical International | United States |
| Harvard Clinical Research Institute | United States |
| Harvard Medical School | United States |
| Harvard School of Public Health | United States |
| Harvard Stem Cell Institute | United States |
| Harvard Univ/Yokohama National Univ | United States |
| Harvard University | United States |
| Hepregen Corporation | United States |
| Horizon Pharma | United States |
| Hospira | United States |
| Hua Medicine | China |
| HungaroTrial | Hungary |
| I | Top of Page |
| IBM Global Business Services | United States |
| IBSA | Switzerland |
| ICAP Ocean Tomo | United States |
| ICDD-sas | France |
| iCo Therapeutics Inc. | Canada |
| Idera Pharmaceuticals | United States |
| IDSC | United States |
| IE SUNG INTERNATIONAL | South Korea |
| immatics biotechnologies GmbH | Germany |
| Immune Pharmaceuticals | United States |
| ImmunoGen, Inc. | United States |
| Immunovaccine Inc | Canada |
| Immutep | France |
| IMS Health | United Kingdom |
| INAGEN | Denmark |
| Indena SpA | Italy |
| Index Ventures | United Kingdom |
| infinity pharmaceuticals | United States |
| Ingeniatrics | Spain |
| InnoCentive, Inc. | United States |
| Innovaro Pharmalicensing | United States |
| INSERM TRANSFERT | France |
| Institut Pasteur | France |
| Institute of Nanotechnology | United Kingdom |
| Insymbiosis | Canada |
| Integrated Project Management | United States |
| Intelliject, Inc. | United States |
| InTouch Life Sciences | United States |
| Inventure Capital | Denmark |
| Invest In Skåne | Sweden |
| INVEST IN SPAIN | Spain |
| Invida Group Pte Ltd | Singapore |
| iPierian, Inc. | United States |
| IPSEN GROUP | United States |
| Ironwood | United States |
| ISU ABXIS | South Korea |
| J | Top of Page |
| Jabil | United States |
| Japan Tobacco Pharma | United States |
| Johnson & Johnson | United States |
| K | Top of Page |
| KAEL-GemVax | South Korea |
| Karo Bio AB | Sweden |
| KBI Biopharma | United States |
| Keck Graduate Institute | United States |
| KemPharm | United States |
| Keryx | United States |
| KEW Group, LLC | United States |
| KineMed | United States |
| King & Spalding | United States |
| Kyorin USA, Inc. | United States |
| L | Top of Page |
| Lakewood Amedex Inc | United States |
| Launchpad Venture Group | United States |
| LFB | France |
| LILLE DEVELOPMENT AGENCY | France |
| Lilly Ventures | United States |
| Linnden Communications | United States |
| Lipid Therapeutics GmbH | Germany |
| Lipideon Biotechnology AG | Switzerland |
| Lipocine Inc | United States |
| LivTech, Inc. | Japan |
| Logical Therapeutics, Inc. | United States |
| Longwood Founders Fund | United States |
| Lonza | United States |
| Lux Capital | United States |
| Lux Research, Inc. | United States |
| luye pharma | China |
| Lycera Corp | United States |
| LYONBIOPOLE | France |
| M | Top of Page |
| MacDougall Biomedical Communications | United States |
| MacroGenics | United States |
| Marina Biotech, Inc. | United States |
| Mass High Tech | United States |
| Mass Life Sciences Center | United States |
| Mass Medical Angels | United States |
| Massachusetts Biomedical Initiatives (MBI) | United States |
| Massbio | United States |
| MassBioEd Foundation | United States |
| MassDevelopment | United States |
| Max Neeman International | United States |
| MBHB | United States |
| MC2 Biotek | Denmark |
| MedCI | United States |
| Medco Health Solutions | United States |
| MEDESIS PHARMA | France |
| MedHealth World | United States |
| MedImmune Ventures | United States |
| MEDINCELL | United States |
| MedPanel, LLC | United States |
| MedTRACK | United Kingdom |
| Meiji Seika Kaisha, Ltd. | United States |
| Merck & Co. | United States |
| Merck Serono | Switzerland |
| Mergermarket | United States |
| Meridian Life Science, Inc. | United States |
| Merrimack Pharmaceuticals, Inc. | United States |
| Mersana Therapeutics, Inc. | United States |
| METABOLYS | France |
| Michael J. Fox Foundation | United States |
| MicroDose Life Sciences, LLC | United States |
| Micromet, Inc. | United States |
| Midatech USA, Inc. | United States |
| Milken Institute | United States |
| Millennium: The Takeda Oncology Company | United States |
| Mintz Levin | United States |
| Mirna Therapeutics Inc. | United States |
| MIT | United States |
| Moberg Derma AB | Sweden |
| Momenta Pharmaceuticals | United States |
| Momotaro-Gene, Inc. | Japan |
| mondobiotech holding ag | Switzerland |
| Morphotek, Inc. | United States |
| Movetis NV | Belgium |
| MP Healthcare Venture Management, Inc. | United States |
| MPM Capital | United States |
| MSI Life Sciences | United States |
| Mudan Associates | United States |
| MVC Corporation | Japan |
| Mylan Inc. | United States |
| N | Top of Page |
| Nanomerics | United Kingdom |
| Nanotechnology Knowledge Transfer Network | United Kingdom |
| Nature Publishing Group | United Kingdom |
| NDA Group AB | United States |
| Neogenix Oncology | United States |
| Neomed Management | United States |
| NeurAxon Inc | Canada |
| Neurim Pharmaceuticals Ltd | Israel |
| NEUROFIT | France |
| NEURON EXPERTS | France |
| NeuroSearch A/S | Denmark |
| NEUROSERVICE | France |
| New York Biotechnology Association | United States |
| NewBridge Pharmaceuticals | United States |
| Newron Pharmaceuticals SpA | Italy |
| NextPharma Technologies | United States |
| NicOx | France |
| Nixon Peabody LLP | United States |
| NKT Therapeutics | United States |
| Norgine | United Kingdom |
| NormOxys, Inc. | United States |
| North England Investment Agency | United States |
| Novacta Biosystems Ltd | United Kingdom |
| Novartis | United States |
| Novartis Option Fund | United States |
| Novavax, Inc. | United States |
| Noven Pharmaceuticals | United States |
| Novo Nordisk A/S | Denmark |
| Novozymes A/S | Denmark |
| NOXXON Pharma | United States |
| NRC Biotechnology Research Institute | Canada |
| Numerate, Inc. | United States |
| NuPathe | United States |
| Nycomed | Switzerland |
| Nycomed Canada Inc. | Canada |
| O | Top of Page |
| Ocean Therapeutics | United States |
| Ockham | United States |
| OctoPlus N.V. | Netherlands |
| On Point | United States |
| On-Q-ity | United States |
| Oncodesign Biotechnology | France |
| Oncoholdings Inc. | United States |
| Oncolix, Inc. | United States |
| OncoMed Pharmaceuticals | United States |
| One Nucleus Ltd | United Kingdom |
| ONLYLYON Aderly | France |
| Ono Pharmaceutical Co., Ltd. | United States |
| OntoChem | Germany |
| Ora, Inc. | United States |
| Organogenesis, Inc. | United States |
| Osteologix, Inc. | United States |
| Otsuka Chemical Co., Ltd. | Japan |
| Oxford Expression Technologies | United Kingdom |
| Oxygen Biotherapeutics | United States |
| P | Top of Page |
| Pacific Biomarkers Inc | United States |
| Pantec Biosolutions AG | Liechtenstein |
| PAREXEL International | United States |
| Partners HealthCare | United States |
| Partners in Pharma LLC | United States |
| Pascal Soares | United States |
| Pasteur Institute of Iran | Iran |
| PCI Synthesis | United States |
| PELVIPHARM | France |
| Penwest Pharmaceutical Co. | United States |
| Pepscan Therapeutics | Netherlands |
| Percivia LLC | United States |
| Pergamum AB | Sweden |
| Pervasis Therapeutics | United States |
| Peter J Solomon LLC | United States |
| Pfizer | United States |
| Pharmatek Laboratories, Inc. | United States |
| PharmaTelevision | United Kingdom |
| PharmaVentures | United Kingdom |
| Pharmovation Limited | United Kingdom |
| PHARNEXT | France |
| Pioneer Market Access Consulting SARL | Germany |
| PlantForm Corp | Canada |
| Point-2-Point Genomics | United Kingdom |
| Polaris Venture Partners Inc. | United States |
| PolyMedix, Inc. | United States |
| PRECLIN Biosystems AG | Switzerland |
| Pressure BioSciences, Inc. | United States |
| PRIAXON AG | Germany |
| Pro-Pharmaceuticals, Inc. | United States |
| Probiodrug | Germany |
| ProMedica CRC | United States |
| ProQuest Investments | United States |
| Proximagen | United Kingdom |
| PRUDENTAS LLC | Russian Federation |
| Pullan Consulting | United States |
| Purdue Pharma L.P. | United States |
| PureTech Ventures | United States |
| PX'THERAPEUTICS | France |
| Q | Top of Page |
| Q Chip Ltd | United Kingdom |
| QCTR | United Kingdom |
| Quest PharmaTech.com | Canada |
| R | Top of Page |
| Receptor Therapeutics Inc. | Canada |
| Recordati S.p.A. | Italy |
| Relay Technology Management, Inc. | United States |
| Rentschler Biotechnologie GmbH | Germany |
| Repligen | United States |
| RESMED | United States |
| Revotar Biopharmaceuticals AG | Germany |
| RHENOVIA PHARMA | France |
| Rho Capital Partners | United States |
| Rib-X Pharmaceuticals | United States |
| Roche | United States |
| RUSSLAN Clinical Research | Isle of Man |
| RXi Pharmaceuticals, Corp. | United States |
| RxMD | United States |
| S | Top of Page |
| Saier biotechnology Inc. | China |
| Sanochemia Pharmazeutika AG | Austria |
| sanofi-aventis | France |
| Santen Pharmaceutical Co., Ltd. | Japan |
| Santhera Pharmaceuticals (Switzerland) Ltd. | Switzerland |
| Satori Pharmaceuticals | United States |
| Schwartz Communications | United States |
| Scientia Advisors | United States |
| Scil Proteins GmbH | Germany |
| Scottish Biomedical | United Kingdom |
| Scottish Development International | United Kingdom |
| Seed Intellectual Property Law Group PLLC | United States |
| SelectX Pharmaceuticals | United States |
| Senexta Therapeutics SA | Switzerland |
| Sentry BioPharma Services, Inc. | United States |
| Sepracor Inc. | United States |
| SERVIRE | Italy |
| SFJ Pharmaceuticals, Inc. | United States |
| Shanghai Medicilon Inc. | China |
| Shire Pharmaceuticals Inc. | United States |
| Sierra Sciences LLC | United States |
| Signature Diagnostics AG | Germany |
| Simon-Kucher & Partners | United States |
| Sistemic Ltd | United States |
| Skyline Diagnostics | Netherlands |
| Skyline Ventures | United States |
| Solid Form Solutions Ltd | United Kingdom |
| Sorrento Therapeutics, Inc. | United States |
| Staatz Business Development | Germany |
| StemCellRX | United States |
| Stemgent | United States |
| Strategic Science & Technologies, LLC | United States |
| Stromedix, Inc. | United States |
| STURGEON CAPITAL MANAGEMENT | United States |
| SuperGen, Inc. | United States |
| Supernus Pharmaceuticals, Inc. | United States |
| SuppreMol GmbH | Germany |
| SurModics Pharmaceuticals | United States |
| Symphogen | United States |
| Synageva BioPharma | United States |
| SynCo Bio Partners B.V. | Netherlands |
| Syndax | United States |
| Synta Pharmaceuticals | United States |
| Syntaxin Ltd | United Kingdom |
| Sysmex America, Inc. | United States |
| T | Top of Page |
| Takeda Pharmaceuticals International | United States |
| Talaris Advisors | United States |
| Taligen Therapeutics | United States |
| Targeted Cell Therapies | United States |
| TCLAND EXPRESSION | France |
| Tectra | Denmark |
| Tempero Pharmaceuticals, Inc. | United States |
| Tengion | United States |
| Tetraphase Pharmaceuticals | United States |
| Teva Pharmaceutical Industries Ltd | Israel |
| The Leukemia & Lymphoma Society | United States |
| The Pfizer Incubator LLC | United States |
| The Salter Group | United States |
| TheBioTechPanel.com | United States |
| Therabel Europe Ltd | Ireland |
| Therapure Biopharma | Canada |
| Theravance, Inc. | United States |
| Third Rock Ventures | United States |
| Thomson Reuters | United States |
| Threshold Pharmaceuticals | United States |
| Tolerx | United States |
| Torrent Pharmaceuticals Ltd | India |
| TRANSGENE | France |
| TransPharma Medical | United States |
| Trial Interactive | United Kingdom |
| TriStar Technology Group, LLC. | United States |
| Tufts Medical Center | United States |
| Tufts University | United States |
| U | Top of Page |
| Ubifrance | United States |
| UCB PHARMA SA | Belgium |
| V | Top of Page |
| Valletta Health Holding | Netherlands |
| Valocor Therapeutics, Inc. | Canada |
| vasopharm GmbH | Germany |
| Veeda | United Kingdom |
| Venture Valuation | Switzerland |
| Ventures West Capital | Canada |
| Vetter Pharma International GmbH | Germany |
| VIB | Belgium |
| Viclink | New Zealand |
| Victory Pharma, Inc. | United States |
| Vitae Pharmaceuticals, Inc. | United States |
| VIVALIS | France |
| Voisin Consulting | United States |
| VTT Technical Research Centre of Finland | Finland |
| Vybion, Incs | United States |
| W | Top of Page |
| Wildwood Ventures Ltd. | United Kingdom |
| WilmerHale LLP | United States |
| Wolters Kluwer Pharma Solutions | United Kingdom |
| Wombat Capital | United States |
| WuXi AppTec, Inc. | China |
| X | Top of Page |
| X-BODY BioSciences | United States |
| Xtal BioStructures Inc. | United States |
| Y | Top of Page |
| Yuhan Corporation | South Korea |
| Z | Top of Page |
| Zalicus, Inc. | United States |
| Zarzatech Inc. | United States |
| Zealand Pharma | Denmark |
| ZenFile | United States |
| ZenithBIO LLC | United States |
| Zyngenia | United States |
